Nuo Therapeutics, Inc. (AURX)

Gross Margin

64.11%

TTM · Period ending:

AURX logo

AURX Gross Margin

Latest reported64.11%
AURX Gross Margin (-200.81% → 64.11%)
High-resolution chart · PNG

AURX gross margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Gross Margin — Annual fiscal periods
Period endingGross Margin
66.9368%
77.8166%
79.2791%
82.8829%
0%
0%
21.5923%
88.1079%
-51.314%
9.8418%
30.7868%
12.7699%
26.9478%
62.9453%
62.3706%
58.759%
77.7946%
71.2532%
56.2448%
47.9207%
41.8047%
37.8638%
30.222%
84.5056%
100%
80.5683%
-200.814%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.